Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

Delayed Data
As of Feb 23
 +4.34 / +3.79%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 165.50, with a high estimate of 180.00 and a low estimate of 114.00. The median estimate represents a +39.16% increase from the last price of 118.93.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.48%
Growthannually 16.25%


Growthquarterly 2.39%
Growthannually 11.88%
Key to the earnings and sales forecast charts.